Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: A multicenter study
暂无分享,去创建一个
M. S. Rezai | F. Ladomenou | Mohammad Reza Navaeifar | Behzad Haghighi Aski | A. Manafi Anari | L. Shahbaznejad | E. Shorafa | M. Mohammadi | Azin Hajialibeig | Seyedeh-Kiana Razavi-Amoli | Fereshteh Rostami-Maskopaee | M. Rahmati | Fatemeh Hosseinzadeh | Seyedenarjes Abootalebi
[1] D. Singh-Grewal,et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison , 2021, Nature Reviews Rheumatology.
[2] E. Wu,et al. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19 , 2021, Current Cardiology Reports.
[3] M. Oster,et al. Demographic and Clinical Factors Associated With Death Among Persons <21 Years Old With Multisystem Inflammatory Syndrome in Children—United States, February 2020–March 2021 , 2021, Open forum infectious diseases.
[4] P. Hashkes,et al. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease , 2021, Scientific Reports.
[5] David A. Williams,et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C) , 2021, Journal of Allergy and Clinical Immunology.
[6] A. Bhutta,et al. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis , 2021, PloS one.
[7] Manish M Patel,et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.
[8] A. Orgun,et al. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey , 2021, Journal of tropical pediatrics.
[9] Jun-bao Du,et al. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment , 2021, World Journal of Pediatrics.
[10] J. Merckx,et al. Multicenter cohort study of multisystem inflammatory syndrome in children (MIS-C) , 2021, medRxiv.
[11] Resul Yılmaz,et al. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia , 2021, Clinical Rheumatology.
[12] M. Qorbani,et al. Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review , 2021, Frontiers in Pediatrics.
[13] M. Oster,et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.
[14] Iqbal Bano,et al. Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children? , 2021, Pakistan journal of medical sciences.
[15] Soo-Young Lee,et al. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019 , 2020, Clinical and experimental pediatrics.
[16] F. Hassani,et al. COVID-19 and multiorgan failure: A narrative review on potential mechanisms , 2020, Journal of Molecular Histology.
[17] Seema Sharma,et al. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. , 2020, The Pediatric infectious disease journal.
[18] Álvaro Freitas Moreira,et al. Multisystem inflammatory syndrome in children: A systematic review , 2020, EClinicalMedicine.
[19] V. Ziaee,et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran , 2020, Epidemiology and Infection.
[20] J. Newburger,et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach , 2020, European Journal of Pediatrics.
[21] Edward Y Lee,et al. Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID. , 2020, AJR. American journal of roentgenology.
[22] Zhe Luo,et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study , 2020, Journal of Intensive Care.
[23] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[24] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[25] Hongzhou Lu,et al. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. , 2020, Bioscience trends.
[26] S. Maskatia,et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.
[27] L. Gostin,et al. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.
[28] J. Antón,et al. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group , 2019, PloS one.
[29] Evelyn P. Whitlock,et al. Screening and Interventions for Childhood Overweight: A Summary of Evidence for the US Preventive Services Task Force , 2005, Pediatrics.